Navigation Links
Stereotyping prime obstacle to women in commercial science
Date:3/12/2013

COLLEGE PARK, Md. - Female professors are almost 50 percent less likely than their male counterparts to be invited to join corporate scientific advisory boards (SABs) and start new companies mainly because of gender stereotyping, says University of Maryland researcher Waverly Ding, an assistant professor of management at the Robert H. Smith School of Business.

Beliefs that women lack leadership and business savvy, and are not capable of helping new ventures attract investment, block their advancement in these areas, she says.

Ding, with co-authors Fiona Murray of MIT and Toby E. Stuart of University of California Berkley, draw this conclusion from survey data and related statistics from the biotech industry and 6,000 U.S. scientists whose careers span 30-plus years. The study, "From Bench to Board: Gender Differences in University Scientists' Participation in Corporate Scientific Advisory Boards," appears in a recent issue of Academy of Management Journal.

The study controlled for the scientists' professional accomplishments, social networks, employer characteristics and proxies for subject interest in commercial science.

"Women are available," says UMD's Ding. "The numbers are there. They just are not being selected." In the data sample's final year (2002), women comprised about 30 percent of about 6,000 PhDs from U.S. universities or research institutions, but just 7 percent (49 of 720) of those scientists served on SABs of 511 U.S. biotech firms. She says this percentage never exceeded 10.2 during the study's 1972-2002 window.

Though her data appears to be the latest available that's specific to the SAB gender breakdown in the biotech industry, Ding says she suspects the percentage of female SAB members serving biotech firms falls below the overall, 12.6-percentage of women on U.S. corporate boards in 2012 (according to an independent study: http://info.gmiratings.com/gmi-ratings-2012-women-on-boards-survey/).

But, she says, academia can effectively counteract the inequity.

"University scientists have helped create at least half of the publicly traded biotech firms operating today, and our data shows a female professor is most likely to draw a science advisory board invitation by tapping into her school's technology transfer office," says Ding. "Biotechnology founders strongly gauge an SAB candidate's reputation and quality of his or her network in determining that individual's business savvy."

But not all institutions formally support such offices even though they "provide an ideal means for academic administrators to raise the profile of their high-performing female scientists," she says. "Networking by way of technology-transfer offices can be useful in promoting the research of women faculty and brokering connections between them and influential members of the entrepreneurship and investment communities."

She concludes the influence factor is a major issue, since gender bias appears most active in high-profile companies backed by high-status venture capitalists. "When female scientists do receive invitations to join boards, they generally come from small start-ups with limited financial backing."

Further measuring the effects of specific areas of research interest and individual career aspiration on the SAB gender gap can deepen the understanding this issue and help erode gender inequity more broadly at the corporate leadership level, says Ding. "Our nation's continued preeminence in science and technology will depend on engaging the best and the brightest, regardless of gender."


'/>"/>

Contact: Greg Muraski
gmuraski@rhsmith.umd.edu
301-892-0973
University of Maryland
Source:Eurekalert

Related biology news :

1. Winners of the 2012 F1000Prime Faculty Member of the Year Awards
2. Marginal lands are prime fuel source for alternative energy
3. Study identifies prime source of ocean methane
4. Computer model pinpoints prime materials for efficient carbon capture
5. New book celebrates women scientists in the Americas
6. Progesterone may be why pregnant women are more vulnerable to certain infections
7. Genetic signs of alcoholism in women studied for the first time
8. African-American, Caucasian women should take identical vitamin D doses
9. Cancer risk for African-American women with benign breast disease factors Wayne State finds
10. Few pregnant women treated for sexually transmitted infections
11. Geneviève Almouzni to receive the 2013 FEBS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... innovation leader in attendance control systems is proud to announce the introduction of fingerprint ... sure the right employees are actually signing in, and to even control the opening ... ... ... Photo ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology: